Cl. Glenn et al., Linkage and association of tumor necrosis factor receptor 2 locus with hypertension, hypercholesterolemia and plasma shed receptor, HUM MOL GEN, 9(13), 2000, pp. 1943-1949
Tumor necrosis factor (TNF) receptor 2 (TNF-R2) has been implicated in insu
lin resistance and metabolic syndrome disorders, one of which is hypertensi
on (HT). We therefore decided to test markers in and near the TNF-R2 gene (
TNFRSF1B) for linkage and association with HT, as well as hypercholesterole
mia, and plasma levels of the shed soluble receptor (sTNF-R2), The linkage
study, which involved 200 HT Anglo-Celtic Caucasian sibpairs, indicated a s
harp, significant linkage peak centered at TNFRSF1B (multipoint maximum LOD
score = 2.6 and 3.1 by weighted and unweighted MAPMAKER/SIBS, respectively
; two-point LOD scores = 2.9 and 3.9 by weighted and unweighted SPLINK, res
pectively; P = 10(-4) by identical-by-state chi(2)). The case-control study
in 134 unrelated HTs who were the offspring of two HT parents and 197 norm
otensives (NTs) whose parents were both NTs, indicated possible association
of TNFRSF1B with HT by haplotype analysis (P = 0.008). Plasma sTNF-R2 was
elevated in HTs (P < 0.0001) and showed a correlation with systolic and dia
stolic blood pressure (BP) (P < 0.0002). A genotypic effect of TNFRSF1B on
plasma sTNF-R2, as well as total, low and high density lipoprotein choleste
rol, and diastolic BP was observed, These observations are consistent with
a scheme leading to raised BP and hypercholesterolemia. In conclusion, TNFR
SF1B may be a candidate gene for HT and other metabolic syndrome abnormalit
ies.